ABSTRACT The balance between reactive oxygen species production and antioxidant defense enzymes in embryos is necessary for normal embryogenesis. To determine the dynamic expression profile of manganese superoxide dismutase (MnSOD) in embryos, which is an essential antioxidant enzyme in embryonic organogenesis, the expression level and distribution of MnSOD mRNA and protein were investigated in mouse embryos, as well as extraembryonic tissues on embryonic days (EDs) 7.5-18.5. MnSOD mRNA levels were remarkably high in extraembryonic tissues rather than in embryos during these periods. MnSOD protein levels were also higher in extraembryonic tissues than in embryos until ED 16.5, but the opposite trend was found after ED 17.5. MnSOD mRNA was observed in the chorion, allantois, amnion, ectoderm, ectoplacental cone and neural fold at ED 7.5 and in the neural fold, gut, ectoplacental cone, outer extraembryonic membranes and primitive heart at ED 8.5. After removing the extraembryonic tissues, the prominent expression of MnSOD mRNA in embryos was seen in the sensory organs, central nervous system and limbs on EDs 9.5-12.5 and in the ganglia, spinal cord, sensory organ epithelia, lung, blood cells and vessels, intestinal and skin epithelia, hepatocytes and thymus on EDs 13.5-18.5. Strong MnSOD immunoreactivity was observed in the choroid plexus, ganglia, myocardium, blood vessels, heapatocytes, pancreatic acinus, osteogenic tissues, brown adipose tissue, thymus and skin. These findings suggest that MnSOD is mainly produced from extraembryonic tissues and then may be utilized to protect the embryos against endogenous or exogenous oxidative stress during embryogenesis.
ders, neurodegeneration, and mitochondrial biochemical defects (Melov et al., 1998; Qi et al., 2003; Samper et al., 2003; Hinerfeld et al., 2004; Lynn et al., 2005; Martin et al., 2006) . On the contrary, transgenic mice overexpressing MnSOD in pulmonary tissue are conspicuously resistant to oxygen toxicity (Ibrahim et al., 2000) , and those overxpressing MnSOD in the heart are protective against adriamycin-induced cardiac toxicity (Cole et al., 2006) or myocardial ischemia-reperfusion injury (Chen et al., 1998) . Additionally, overexpression of MnSOD in the lungs of mice prior to irradiation treatment prevents acute and chronic irradiation-induced damage (Carpenter et al., 2005) .
tant for embryogenesis, and thus it is necessary to acquire further levels were higher in extraembryonic tissues than embryos until ED 16.5 (1.2-to 3.2-fold), but the reverse pattern was observed in the embryos during development (Fig. 2) . In extraembryonic tissues, although the MnSOD protein level was highest on EDs 8.5-9.5, it was slightly reduced after ED 10.5 and was lowest at ED 18.5 ( Fig. 2) .
Localization of MnSOD mRNA in whole mount embryos of EDs 7.5-12. 5 At ED 7.5, MnSOD mRNA was expressed in the chorion, amnion, ectoderm, neural fold, and ectoplacental cone (Fig. 3A) . At ED 8.5, signal was detected in the neural fold, primitive heart, gut, ectoplacental cone, and outer extraembryonic membranes (Fig.  3B) . After removing the extraembryonic tissues, MnSOD transcript was detected in brain including the telencephalon, mesencephalon, and myelencephalon, spinal cord, branchial bar I (mandibular arch), ventricle of heart, limb buds, and gut on EDs 9.5-10.5 ( Fig. 3 C,D) . 
Results
Temporal levels of MnSOD mRNA and protein in developing embryos and extraembryonic tissues during organogenesis mRNA was assessed using quantitative real-time PCR analysis. As shown in Fig. 1 , MnSOD mRNA was detected in all the embryos and extraembryonic tissues including placenta on EDs 7.5-18.5. MnSOD mRNA level was higher in the extraembryonic tissues than in embryos during the gestation period examined (10-to 47-fold on EDs 7.5-13.5 and then 2-to 5-fold until ED 18.5). MnSOD mRNA in extraembryonic tissues was expressed at a high level until ED 12.5 and then showed a decreasing pattern after ED13.5. On the other hand, the signal for MnSOD mRNA in embryos increased gradually during the whole gestational periods examined.
As analyzed by Western blotting, MnSOD protein was detected in embryos and extraembryonic tissues including placenta on EDs 8. 5-18.5 . MnSOD protein On EDs 11.5-12.5, MnSOD mRNA was expressed in the telencephalon, mesencephalon, spinal cord, and limb buds (Fig. 3 E,F) .
Localization of MnSOD mRNA in embryonic organs of EDs 13.5-18. 5 MnSOD mRNA was detected in various embryonic tissues on 1. MnSOD mRNA in the developing brain was detected at high levels in the external layers of the cerebral cortex on EDs 13.5 to 18.5 ( Fig. 4A ) and in marginal zone of the cerebellum on ED 18.5 ( Fig. 4B ). Very strong MnSOD signal was observed in the neurons of developing ganglion and spinal cord on EDs 13.5 to 18.5 ( Fig.  4C,D) . MnSOD mRNA was strongly expressed in epithelial cells of the nasal cavity and inner ear after ED 13.5 ( Fig. 4 E,F) . In the developing lung, high levels of MnSOD mRNA were observed in the bronchial epithelium and parenchyma after ED 13.5 ( Fig. 4 G,H). MnSOD signal was detected at a high level after ED 13.5 in blood cells ( Fig. 4I) and at a moderate level in the myocardium on ED 17.5 ( Fig. 4J) . In developing intestines, MnSOD mRNA was more strongly expressed in luminal epithelium than muscular layer on EDs 13.5-15.5, but it was highly expressed in both regions on EDs 16. L) . MnSOD mRNA expression was very strong in hepatocytes and hematopoietic cells of the liver on EDs 13.5-15.5 ( Fig. 4M ) and exclusively in hepatocytes after ED 16.5 ( Fig. 4N ). Strong MnSOD signal was observed in pancreatic acini on EDs 13.5-14.5 and 17.5 ( Fig. 4O ) or pancreatic islet on EDs 14.5-15.5 ( Fig. 4P) . A high level of MnSOD mRNA was detected in submandibular gland after ED 15.5 and in the thymus after ED MnSOD signal was observed in the metanephric tubules after ED 14.5 ( Fig. 4 Q,R) . MnSOD mRNA was abundant in the luminal epithelium and muscular layers of the urinary bladder on EDs 16.5-17.5 (Fig. 4S) . In developing adrenal gland, MnSOD mRNA was highly expressed in the medulla on EDs 13.5-15.5 and 17.5 and in the cortex on EDs 13. 5-14.5 . MnSOD mRNA showed a moderate expression the developing skin, MnSOD mRNA expression was moderate on EDs 14.5-15.5 ( Fig. 4U ) and very high after ED 16.5 (Fig. 4V ). In addition, MnSOD mRNA was remarkably detected in brown adipose tissue on EDs 15. 5 -18.5 (Fig. 4W) . Fig. 5B ), Rathke's pouch (hypophysis) after ED 15.5 (Fig. 5C ), and neurons of the ganglia on EDs 13.5-18.5 ( Fig. 5D ) and spinal cords after ED 16.5 (Fig.  5E ). MnSOD was highly expressed in the epithelia of the inner ear and nasal cavity after ED 15.5. In developing lung tissues, MnSOD showed high expression in the bronchial epithelium after ED 16.5, but moderate expression in parenchyma after ED 15.5 ( Fig. 5F ). Strong MnSOD immunoreactivity was detected in myocardial cells and blood vessels on EDs 13.5-18.5, and in blood cells on EDs 13.5-16.5 ( Fig. 5G and 5H ). In developing intestines, strong MnSOD immunoreactivity was detected in the luminal epithelium after ED 14.5, but showed a moderate level in the muscular layer on EDs 13.5-17.5 (Fig. 5I) . In developing liver, while MnSOD immunoreactivity in hepatocytes was very strong on EDs 13.5-18.5, high signal levels in hematopoietic cells were observed on EDs 13.5-15.5 that then decreased to a moderate level after ED 16.5 (Fig. 5J) . In developing pancreas, MnSOD immunoreactivity was detected at a high level in the acinus, but only moderately in islets on EDs 13.5-18.5 (Fig. 5K) . In developing submandibular glands, high levels of MnSOD were detected on EDs 17.5-18.5. In developing kidneys, MnSOD showed a similar immunoreactivity level in metanephric corpuscles and tubules on EDs 13.5-14.5, but after ED 15.5, this was higher in metanephric tubules than metanephric corpuscles (Fig. 5L) . In developing adrenal glands, MnSOD immunoreactivity was very strong in the medulla on EDs 14.5 and 16.5, and in the cortex on ED 18.5 ( Fig. 5 M,N) . Strong MnSOD immunoreactivity was observed in the developing thymus and bones after ED 13.5 (Fig. 5O) . MnSOD was abundantly ob- (A, B, D, F-L, P, Q, and T-V); 200x for panels (C, N, and O) ; 400x for panel (M) . served in skeletal muscle after ED 16.5. MnSOD signal was very strong in the skin after ED 16.5 and brown adipose tissues after ED 15.5 ( Fig. 5 P,Q) .
Distribution of immunoreactive

Discussion
During normal embryo development, the embryos generate ROS by both aerobic and anaerobic metabolic pathways, and require an antioxidant defense system (Ornoy, 2007) . Need for antioxidant defense is changed according to the time and site of organogenesis (el-Hage and Singh, 1990) . ROS are produced during normal pregnancy through the metabolic activity of embryo and placental mitochondria (Dennery, 2007; Myatt, 2006) . Several antioxidative defense mechanisms are present in both embryos peroxidase (cGPx) which removes H 2 O 2 by coupling its reduction to H 2 O with oxidation of reduced glutathione, is detected in all the embryos retrieved from EDs 7.5 to 18. 5 (Baek et al., 2005) . SOD1 mRNA is increased at late stages of embryonic development, but maintains a constant level of expression in extraembryonic tissues during organogenesis (Yon et al., 2008a) . In embryo, SOD1 protein is observed at the lowest level on ED 9.5-11.5, and the highest level on ED 17.5-18.5, while levels remained constant in the extraembryonic tissues during all developmental stages (Yon et al of the selenoprotein P (SePP) which functions principally as a selenium transporter and antioxidant is high in extraembryonic tissues, as compared to embryos, on EDs 7.5-13.5. However, the level is higher in embryos than in extraembryonic tissues on EDs 14.5-15.5, but is similar in both tissues during the subsequent periods prior to birth (Lee et al., 2008) . In the present study, MnSOD mRNA was highly expressed in extraembryonic tissues rather than embryos. MnSOD mRNA expression constantly increased in embryos during development, but in extraembryonic tissues, MnSOD mRNA was expressed a high level until ED 12.5 before decreasing after ED 13.5. MnSOD protein levels were also higher in extraembryonic tissues than embryos until ED 16.5; the reverse was observed after ED that the expression of various antioxidant enzymes including
organs. (A) ED 18.5 cerebrum. (B) ED 14.5 ependymal cells of choroid plexus. (C) ED 18.5 hypophysis. (D) ED 18.5 trigeminal ganglion. (E) ED 14.5 spinal cord; neurons (arrows). (F) ED 16.5 lung; bronchus (br) and blood vessels (bv). (G) ED 15.5 ventricle of heart. (H) ED 14.5 blood cells. (I) ED 16.5 intestine. (J) ED 15.5 hepatocytes and hematopoietic cells of liver. (K) ED 16.5 pancreas. (L) ED 18.5 kidney. (M) ED 14.5 adrenal gland. (N) ED 18.5 adrenal gland. (O) ED 13.5 osteogenic tissue. (P) ED 18.5 skin. (Q) ED 17.5 brown fat. Magnifications: 40x for panels (G, O, P, and Q); 100x for panels (A-F, I, K, L, and N;) 200x for panels (H and M); 400 x for panel (J).
MnSOD may be changed in embryos and extraembryonic tissues according to ontogenic stages and may play an important part in embryogenesis.
blast and differentiate into structures surrounding the implanting embryo (Bell et al., 1983) . During early postimplantational periods, a process of gastrulation and early organogenesis causes increment in ROS formation. Multiple compensatory protection mechanisms exist in the developing embryo and its environment (Dennery, 2007; Jansson and Powell, 2007; Ornoy, 2007) . placenta receives nutrients, oxygen, antibodies, and hormones from maternal blood and passes waste products (Hanson, 2007) . development (Chen et al., 1999) . As the fetus moves from a hypoxic to a relatively hyperoxic environment, accompanying changes in antioxidant enzymes constitute a compensatory mechanism aimed at protecting the newborn from oxidative stress (Khan and Black, 2003) . In the present study, MnSOD mRNA was found in chorion, allantois, and amnion as well as extraembryonic tissues including placenta. Furthermore, MnSOD levels were high in extraembryonic tissues compared to the embryos until ED 16.5, but the reverse was observed after ED 17.5. MnSOD showed a gradual increase in the embryos during development. It is presumed that MnSOD might serve as an important player at the maternal-fetal interface which has a central role in fetal growth by directly regulating nutrients, respiratory gases, and signaling molecules.
In the early developmental stage, the central nervous system (CNS) begins as a simple neural plate region of the ectoderm and by the dorsal fusion of the neural folds and differentiates into the spinal cord and the brain (Padmanabhan, 2006) . In the present study, MnSOD mRNA was abundantly expressed in the neural ectoderm and neural fold on EDs 7.5-8.5. Furthermore, MnSOD mRNA (EDs 9.5-18.5) and its protein (EDs 13.5-18.5) were abundantly expressed in the CNS including the prosencephalon, telencephalon, mesencephalon, metencephalon, and spinal cord, and various SOD1, cGPx, and SePP (Baek et al., 2005; Lee et al., 2008; Yon et al., 2008 a,b) . Previous studies found that the developing limb and brain in fetus are the most sensitive to O 2 .-formation (Fantel et al., 1995) . Neurons in the brain consume high amounts of oxygen, and are thereby constantly submitted to oxidative stress. SOD1 is mainly found in neuronal cells (Peluffo et al -gether, the data presented in this study suggest the possibility that antioxidant enzymes including MnSOD may play an important part in development of the nervous system as free radical scavengers.
which arise suddenly at birth, which may induce oxidative injury in neonates (Araujo et al differentiated to enable protection, absorption, secretion, excretion, and formation of a barrier for selective permeation (GonzalezMariscal et al., 2005) . In current study, MnSOD was ubiquitously expressed in post-implatational mouse embryonic tissues. In particular, MnSOD appeared at high levels in the developmental epithelial systems such as metanephric tubules, bronchus, skin, whisker follicles, ependymal epithelium of choroid plexus, luminal epithelia in inner ear and nasal cavities, and intestinal mucosal studies of rat tissues (Munim et al., 1992) as well as antioxidant enzymes such as SOD1, cGPx, and SePP (Baek et al., 2005; Lee et al., 2008; Yon et al MnSOD (SOD2) may function as the outmost antioxidant enzyme to protect embryos against detrimental ROS generated from fetal and maternal interaction during embryogenesis.
2 .-are generated from complexes I and III of the electron transport chain as a byproduct of oxidative phosphorylation in mitochondria (Rossignol et al., 2003) . MnSOD is highly expressed in adult organs that contain a large number energy consumption rates (Guérin et al., 2001) . MnSOD knockout mice exhibit prenatal and neonatal lethality which is associated with defects in the heart, skeletal muscle, liver, and brain (Lebovitz et al., 1996; Li et al., 1995; Xia et al., 2006) . In our study, MnSOD was strongly detected in developing brain, heart, liver, pancreas, may act as a critical antioxidant enzyme in organs with cells that have an abundance of mitochondria.
ROS are vital to normal developmental processes such as proliferation and differentiation (Dennery, 2007) . In our study, strong MnSOD expression was observed in sites of active differentiation and proliferation such as chondrocytes of osteogenic tissues, hematopoietic cells of the liver, and circulatory blood cells. After birth, erythrocytes use SOD1 to scavenge O 2 but carry only the SOD1 protein, not mRNA, as they lack mitochondria. Neutrophils produce enormous quantities of O 2 through the activity of cellular oxidant-generating systems (Sheppard et al., 2005) . High levels of SOD1 activity are present in cartilage and connective tissues (Frederiks and Bosch, 1997) , and a low molecular weight of SOD damage associated with collagen-induced arthritis (Cuzzocrea et al SOD1 may act as an important antioxidant in osteogenesis and hematopoiesis during embryonic development.
In this study, MnSOD was very strongly expressed in brown adipose tissue after ED 15.5. Brown adipose tissue serves as a thermogenic organ in placental mammals to maintain body temperature in cold environments (Cannon and Nedergaard, 2004) and contains many mitochondria, fat vacuoles, and a blood supply (Dawkins and Hull, 1964) . Cold exposure increases MnSOD activity in interscapular brown adipose tissue in order to protect the tissue from ROS generated as a result of intense metabolic et al important role in embryonic protection against ROS produced in the mitochondrial metabolism of brown adipose tissues during the gestational periods. In summary, MnSOD levels varied widely in different cell types, and even within a particular cell type, during the course of embryonic development. Although the expression patterns between mRNA and protein of MnSOD were slightly different in the mouse embryonic organs, suggesting that the production site and functional site for MnSOD during embryogenesis may be different somewhat, most of MnSOD was expressed in embryos and extraembryonic tissues is necessary for protecting the embryos against endogenous or results obtained in this study provide information which is used as a basis to study the functions of MnSOD relative to various diseases.
Materials and Methods
Experimental animals
Male and female ICR mice (8~10 weeks old) were purchased from a commercial breeder, Biogenomics Co. (Seoul, South Korea). One male and three female mice were mated overnight in our facilities, which were maintained at 21 ± 2°C and 55 ± 10% relative humidity on a 12 h light/dark cycle. Pregnancy was cervical dislocation and the embryos and extraembryonic tissues including the ectoplacental cone (placenta), chorion, amnion, allantois, yolk sac, and Reichert's membrane were recovered at EDs 7.5 to 18.5. All experiments were performed in accordance with the "Guide for Care and Use of Animals" (Chungbuk National University Animal Care Committee according to NIH #86-23).
Total RNA isolation and quantitative RT-PCR analysis
RNA (3 CA, USA) as previously described (Yon et al., 2008a) . MnSOD -Demand #Mm00690588 (Applied Biosystems). GAPDH mRNA was the internal standard (Assay on Demand #4352932E, Applied Biosystems) for normalizing MnSOD mRNA to GAPDH mRNA, which were used to precisely quantify the levels of MnSOD expression in embryos and extraembryonic tissues, were calculated with the standard curves.
In situ hybridization in whole embryos and embryonic tissues in situ (Promega, Madison, WI, USA) containing the mouse MnSOD cDNA clones (accession number: NM_013671, fragment; 287 bp) was linearized with SpeI or NcoI restriction enzymes. Digoxigenin-(DIG; Roche, Penzberg, Germany) labeled sense or antisense riboprobes for MnSOD were generated via in vitro Japan) at 37°C for 60 min. For whole-mount in situ hybridization of embryos, in situ hybridization procedure for tissue sections (EDs 13.5-18.5) was carried out as previously described (Baek et al., 2005) . Hybridization signals were detected using an alkaline phosphatase-conjugated antibody against DIG (Roche) and 5-bromo-4-chloro-3-indolyl phosphate and nitro-blue tetrazolium solution (Roche) substrate.
Protein extraction and Western blotting
bryonic tissues. Protein extraction and Western blotting were conducted as previously described (Yon et al purchased from Stressgen (Ann arbor, MI, USA) and the anti--actin antibody was peroxidase-linked anti-rabbit IgG antibody was purchased from Cell Signaling. Membranes were incubated with the horseradish peroxidase-conjugated secondary antibody (1:1000; Cell Signaling) for 1 h at room temperature, visualized using a Western Lighting Chemiluminescence reagent (Millipore, Billerica, MA, USA) according to the manufacturer's protocol, and photographed (Gel Doc and normalized using PDQuest Image software (Bio-Rad). Experiments were
Immunohistochemistry
For immunohistochemical analysis, mouse embryos obtained on EDs 13.5-m embryo sagittal sections were placed vol) hydrogen peroxide, and then processed in a microwave oven (in 10 mM sodium citrate buffer, pH 6.5, for 15 minutes at 700 W). After blocking with 1.5% the sections were incubated with a rabbit anti-MnSOD polyclonal antibody (dilution, 1:100; Stressgen) for 1 h at room temperature. Next, the sections were incubated with a biotinylated secondary antibody [dilution, 1:2000; Vectastain min at room temperature and then with the peroxidase-conjugated biotin-avidin complex (dilution, 1:1000) for 40 min at room temperature. Finally, the bound peroxidase was revealed by immersing the sections in diaminobenzidine (Vector Laboratories). Sections were rehydrated for 15 min in deionized water to remove
Negative control experiments for the antibodies were performed as above with the omission of the primary antibody.
Statistical analysis
Expression differences of MnSOD mRNA and protein between embryos and extraembryonic tissues at each embryonic stage were assessed via oneway ANOVA followed by Student t-test. All analyses were conducted using a Graphpad Prism software, version 5 (GraphPad Software Inc., La Jolla, CA, -sed as mean ± SD.
